These effects are predominantly mediated via mineralocorticoid receptor (MR) activation in cardiomyocytes and cardiac fibroblasts, and are further amplified by mechanisms driven by oxidative stress, inflammation, and endothelial dysfunction. The gene discussed is NR3C2; the disease is endothelial dysfunction.